1 min read
The Business Pharmacy: Rita Trehan
In our final instalment of The Business Pharmacy series, Rita Trehan, the founder and CEO of DARE Worldwide, shares her 'prescription' for prosperity.
Read MoreManage your equity and shareholders
Share schemes & options
Fundraising
Equity management
Start a business
Company valuations
Launch funds, evalute deals & invest
Special Purpose Vehicles (SPV)
Manage your portfolio
Model future scenarios
Powerful tools and five-star support
Employee share schemes
Predictable pricing and no hidden charges
For startups
For scaleups & SMEs
For larger companies
Ideas, insight and tools to help you grow
1 min read
In our final instalment of The Business Pharmacy series, Rita Trehan, the founder and CEO of DARE Worldwide, shares her 'prescription' for prosperity.
Read More2 min read
Want to know real-life founders' recipes for success? Look no further than our Business Pharmacy, where entrepreneurs share their 'prescription' for...
3 min read
In 2021, we launched our #FounderStories series, where we collect and share the voices of company founders from different sectors.
3 min read
What's the secret behind successful founders? At The Business Pharmacy, we're here to find out...
3 min read
Step into The Business Pharmacy. And discover the secrets behind many a founders' success.
2 min read
The Business Pharmacy is open. Come on in! Here founders tell us what makes them tick and helps them thrive in business.
2 min read
You've reached The Business Pharmacy, where entrepreneurs share their prescription for prosperity, their recipe for success.
2 min read
Company founders face an unenviable series of challenges as they try to plot that successful path from inception to growth and eventual exit from...
5 min read
Last updated: 1 October 2024. Your company has offered you shares or share options. Great! Though you might be wondering: now what? What’s really in...
4 min read
Share schemes! You might equate them with the cut and thrust of the tech world but did you know that they are becoming more common across all...